Key result
Lidocaine cuts renal nerve activity ~82% to enable afferent signal isolation in rats.
This study demonstrates a feasible novel method for directly measuring afferent renal nerve activity in unanaesthetised rats, which could aid in investigating reno-renal reflexes and the pathophysiology of hypertension.
Enables direct afferent renal nerve recording in awake rats; leaves open translation to human hypertension research.
This study introduces a novel method for recording afferent renal nerve activity (ARNA) in unanaesthetised rats. A bipolar electrode was surgically implanted on the left renal nerve to record renal nerve activity (RNA), and efferent renal nerve activity (ERNA) was selectively blocked by administering 5% lidocaine via a polyurethane catheter placed over the renal artery-aorta junction. Lidocaine administration reduced RNA by approximately 82% relative to pre-lidocaine values, enabling the isolation of afferent nerve signals. Intrarenal arterial infusion of increasing doses of bradykinin (10, 20, 40, and 80 µg/kg) following lidocaine infusion produced a significant increase in ARNA, confirming preserved afferent function. This demonstrates the feasibility of this approach for investigating reno-renal reflexes and the dynamic interplay between ARNA and ERNA, with implications for understanding homeostatic regulation and the pathophysiology of conditions such as hypertension and kidney disease.
No takes yet. Share an insight, caveat, or question.
Abdulla et al. (2026) studied this question. Lidocaine and bradykinin vs. Pre-lidocaine baseline was evaluated on Renal nerve activity (RNA). Administration of 5% lidocaine reduced renal nerve activity by approximately 82% relative to baseline, enabling the isolation of afferent nerve signals in unanaesthetised rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: